Thu, Apr 27, 2017 | updated 02:55 AM IST

Taking Tamoxifen does not escalate risk of uterine cancer: Study

Updated: Oct 05, 2016 11:22 IST      
Taking Tamoxifen does not escalate risk of uterine cancer: Study

Washington D.C. (USA), Oct. 5 (ANI): A recent study carried out by Loyola Medicine researchers shuns the commonly spread belief that breast cancer drug Tamoxifen could increase the risk of uterine cancer.

The study carried out by Drs. Kathy S. Albain and Ronald K. Potkul enrolled 296 eligible post-menopausal breast patients with a type of early-stage breast cancer called estrogens receptor-positive.

Patients were randomly assigned to take Tamoxifen alone or Tamoxifen plus the hormone progestin.

They were followed and assessed at years two and five.

Researchers predicted that taking progestin would decrease the risk of abnormalities that can develop into uterine cancer.

Such abnormalities occur in the endometrium (inner lining of the uterus).

At year two, the primary time point, researchers evaluated 89 women who took Tamoxifen alone and 80 women who took Tamoxifen plus progestin.

There were five endometrial abnormalities in the Tamoxifen-alone group and one abnormality in the Tamoxifen-plus-progestin group.

This difference was not statistically significant.

All abnormalities were benign.

Only one additional benign abnormality was found at five years. No cancers were detected at two years or five years.

Two years after treatment began, only 6 percent of the patients in the Tamoxifen-alone group, and 3.6 percent in both groups combined had benign endometrial abnormalities.

Based on previous studies, researchers had projected that 30 percent of the women in the Tamoxifen-alone group would show endometrial

abnormalities.

Corresponding author is Kathy S. Albain said the reason the abnormality rate was much lower than expected most likely was due to the study's screening requirements.

All women recruited for the study underwent uterine ultrasound exams before taking tamoxifen.

If the ultrasounds showed a thickening of the inner lining of the uterus greater than 5 mm, a biopsy was performed.

If the biopsy showed an endometrial abnormality, the woman was excluded from the study.

"For women who are concerned about taking tamoxifen to treat or prevent breast cancer, our study suggests that a normal ultrasound before treatment may provide additional reassurance," Albain added.

Tamoxifen is a highly effective drug that is used both to treat breast cancer and help prevent breast cancer in healthy women who are at high

risk of developing the disease.

The first author of the study Ronald K. Potkul said, "However, many women who would benefit from taking tamoxifen fail to do so because they fear getting endometrial cancer. Our study found that for women, who did not have endometrial abnormalities when they began taking Tamoxifen, there was a very low rate of developing pre-malignant conditions."

The median age of the women in the study was 59.5 years.

They underwent endometrial ultrasounds at the beginning of the study and after two years and five years.

After two years, 67 percent of the women in the tamoxifen-alone group had a thickening of the inner lining of the uterus greater than 5 mm, compared with 60 percent of the women in the tamoxifen-plus-progestin group.

This difference was not statistically significant.

All women, who had a thickness greater than 5 mm underwent subsequent biopsies.

The biopsies revealed five cases of endometrial abnormalities in the Tamoxifen group, four cases of proliferative endometrium (more cells

than normal lining the uterus) and one case of simple hyperplasia (non-malignant clumping of cells).

One woman in the Tamoxifen-plus progestin group had an abnormality (proliferative endometrium).

None of the abnormalities in either group developed into uterine cancer.

Although there were more endometrial abnormalities in the Tamoxifen-alone group, the difference was not large enough to be statistically significant.

It would require a follow-up trial with thousands of women to determine whether adding progestin to Tamoxifen truly reduces the risk of uterine cancer.

"These data could potentially reassure certain postmenopausal women who fear endometrial side effects of Tamoxifen, but would otherwise benefit from nstituting this important adjuvant breast cancer and breast cancer chemoprevention therapy. However, validation in a larger trial is needed first before changing practice in all asymptomatic postmenopausal women," researchers concluded.

The multi-center study was published in the Nature journal, Breast Cancer. (ANI)

Lung for Long: Gasp No More

Updated: Apr 26, 2017 18:45 IST     

New Delhi [India], Apr 26 (ANI-Businesswire India): Lungs in Delhi seem to be in dire straits. In the midst of ever thickening air pollution and lifestyle gone astray, lung power is ebbing fast. Data emerging from April 25 lung health camp organized in iconic Press Club of India (PCI) on the occasion of World Asthma Day pressed panic button as regards lung health of the capital city.

Full Story >>

Risk of obesity influenced by changes in our genes

Updated: Apr 26, 2017 15:22 IST     

New Delhi [India], Apr 26 (ANI): According to new study, a child's risk of obesity while growing up can be influenced by modifications to their DNA prior to birth.

Full Story >>

Patient with rare knee cancer undergoes life saving surgery

Updated: Apr 26, 2017 13:52 IST     

New Delhi [India], Apr 26 (ANI): A resident of Ganganager, in Rajasthan, was diagnosed of Large Soft Tissue Sarcoma (9Kg), with Neuro Vascular involvement.

Full Story >>

Here`s how protein impacts intellectual disability

Updated: Apr 26, 2017 07:36 IST     

Washington D.C. [USA], Apr 26 (ANI): A new study has paved the way for the potential treatments of intellectual disability and other neurodevelopmental disorders.

Full Story >>

Stem cells can help identify neuronal defects, suggests Study

Updated: Apr 25, 2017 12:26 IST     

Washington D.C. [USA], Apr 25 (ANI): According to a recent study, the researchers used stem cells derived from patients with Angelman syndrome to identify the underlying cellular defects that cause the rare neurogenetic disorder.

Full Story >>

#WorldMalariaDay: Effective steps to prevent Malaria

Updated: Apr 25, 2017 11:01 IST     

New Delhi [India], Apr 25 (ANI): The theme for World Malaria Day this year is "End Malaria for Good".

Full Story >>

Artificial Intelligence may help in diagnosing Tuberoculosis

Updated: Apr 25, 2017 11:01 IST     

Washington D.C. [USA], Apr 25 (ANI): If you are a patient of Tuberculosis, then we might have some good news for you.

Full Story >>

London [UK], Apr 25 (ANI): According to a new study, only one in five victims with serious injuries caused by child abuse in England and Wales gets treated at a major trauma centre.

Full Story >>

Gene reveals cause of fatal childhood disorder: Study

Updated: Apr 24, 2017 17:51 IST     

New Delhi [India], Apr 24 (ANI): A gene, involved in brain development, which can lead to severe disability and infant death, has been identified by scientists.

Full Story >>

Alcohol: the modern age liver killer

Updated: Apr 24, 2017 17:51 IST     

New Delhi [India], Apr 24 (ANI): Alcohol is predominantly metabolized through liver, hence its cumulative toxicity over years play important role in liver diseases or pancreatic diseases.

Full Story >>

Washington D.C. [USA], April 24 (ANI): Due to increasing deaths because of prostate cancer among men, US researchers have suggested a special screening more frequently and at an early age to avoid the development of preclinical prostate cancer - that is not symptomatic - to advanced stages.

Full Story >>

Love guzzling diet sodas? Here is why you should NOT

Updated: Apr 24, 2017 07:02 IST     

New York [U.S.], Apr. 24 (ANI): Still downing gallons of diet soda despite knowing that it wrecks your body? Maybe the knowledge of artificially sweetened beverages taking a toll on your brain as well ought to make an impact on your unhealthy habit.

Full Story >>

Washington D.C. [USA], Apr 23 (ANI): A recent study has demonstrated that in the general population, central obesity, insulin resistance, diabetes, lipid abnormalities and high alcohol consumption were the strongest predictors of severe liver disease.

Full Story >>

Breastmilk may help detect your cancer risk

Updated: Apr 23, 2017 11:50 IST     

Washington D.C. [USA], Apr 23 (ANI): Breastmilk might offer clues about a woman's cancer risk, according to a recent research.

Full Story >>

Soon, new weapon in war against obesity

Updated: Apr 23, 2017 11:14 IST     

Washington D.C. [USA], Apr 23 (ANI): A team of scientists has uncovered a potential approach to combat obesity.

Full Story >>

Turns out, being obese is worse than smoking

Updated: Apr 23, 2017 10:52 IST     

Washington D.C. [USA], Apr 23 (ANI): You may want to shed those extra kilos as a recent study has found obesity as a top cause of preventable life-years lost.

Full Story >>

Washington D.C. [USA], Apr 23 (ANI): Testing for molecular markers in the urine of kidney transplant patients could reveal whether the transplant is failing and why, according to a recent research.

Full Story >>

From urine to blood: How antibiotic resistance spreads

Updated: Apr 23, 2017 09:25 IST     

Washington D.C. [USA], Apr 23 (ANI): People with drug-resistant bacteria in their urine or stool samples are at an increased risk of developing Sepsis, a bloodstream infection that is also resistant to certain antibiotics, according to a recent study.

Full Story >>

Move over contact lenses, LASIK is better

Updated: Apr 22, 2017 18:05 IST     

Washington D.C. [USA], April 22 (ANI): Good news for those who underwent LASIK (laser-assisted in situ keratomileusis) for correction of their vision, as a recent study has found that the rate of cornea infection is lower.

Full Story >>

Early detection of oral cancer can increase survival chances

Updated: Apr 22, 2017 08:03 IST     

New Delhi [India], Apr. 22 (ANI): In today's era of booming medical advancements, the chances of survival from cancer can be increased, if it is detected at an early stage.

Full Story >>